Author Archives | admin

About admin

Replacement of Bortezomib with Carfilzomib for Multiple Myeloma Patients Progressing from Bortezomib Combination Therapy

March 5, 2017

0 Comments

J R Berenson1,2,3, J D Hilger2, O Yellin2, R Dichmann4, D Patel-Donnelly5, R V Boccia6, A Bessudo7, L Stampleman8, D Gravenor9, S Eshaghian10, Y Nassir11, R A Swift3 and R A Vescio10 1Department of Hematology/Oncology, Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA 2Oncotherapeutics, West Hollywood, CA, USA 3James R Berenson, MD, Inc., West Hollywood, CA, USA 4Department of Medical Oncology and Hematology, Central Coast […]

Continue reading...

Advances in the Management of Multiple Myeloma

March 1, 2017

0 Comments

James R Berenson, MD,abc Tanya M Spektor, PhD,c and James Wang, MDab aInstitute for Myeloma and Bone Cancer Research; bJames R Berenson, MD, Inc; and cOncotherapeutics, West Hollywood, California Correspondence: James R Berenson, MD; jberenson@imbcr.org. Disclosures: Dr Berenson is a consultant for and receives honoraria and research funding from Takeda, Amgen, Jansen, Celgene, and Bristol-Meyers-Squibb. […]

Continue reading...

To Transplant or Not To Transplant in Multiple Myeloma

March 1, 2017

0 Comments

Clinical Advances in Hematology & Oncology Authors: James R. Berenson, MD, Claudia Andreu-Vieyra, PhD, Sergio Giralt, MD May 2014, Volume 12, Issue 5 High-dose therapy in combination with autologous stem cell transplantation (ASCT) has become the standard of care for younger multiple myeloma patients. Is ASCT still the best treatment for these patients in the […]

Continue reading...

I Have WHAT? An Interview With Patient Advocate Debra Berenson

May 24, 2016

0 Comments

Interview with Debra Berenson, myeloma patient advocate, wife of myeloma expert Dr. James Berenson, and author of the book, I HAVE WHAT?. Debra has collected stories, insights, and tools for and from patients and their families with myeloma and related diseases. The second half of the book  includes information and advice from doctors and other healthcare professionals who treat […]

Continue reading...

Full Show: A New BCMA Test to Track Multiple Myeloma Levels with Dr. James R. Berenson, MD, IMBCR

February 22, 2016

0 Comments

Continue reading...

IMBCR Identifies New Treatments for Myeloma in 2015!

July 17, 2015

0 Comments

First, we have made much progress on our new protein marker called B-cell maturation antigen (BCMA) that was initially found in the blood of myeloma patients. The level of this single serum marker predicts patient’s long-term outcomes. It also correlates with how the patient is doing in that very low levels are associated with patients […]

Continue reading...

KIIS Cares Interview

May 21, 2015

0 Comments

What: Myeloma is a disease in your bone marrow. Inside your bone marrow are the cells that make your blood, your red cells, your white cells, and your platelets. This plays a key role in maintaining the strength of the bone. Why: There have been several recent breakthroughs for the treatment of multiple myeloma patients […]

Continue reading...

Counterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?

April 13, 2015

0 Comments

By Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Multiple myeloma is an incurable disease, and patients who respond to treatment eventually relapse—which makes long-term maintenance therapy an appealing option. But is a treatment with an unclear effect on overall survival worth the side effects and financial cost? In this month’s […]

Continue reading...

Talking About Myeloma with Loved Ones

February 6, 2015

0 Comments

Do you feel the Love? The New Year is here. Perhaps you have been newly diagnosed? Whether a Myeloma warrior, or new to the world of MM, talking about the disease with loved ones can be difficult, at best. What is Multiple Myeloma anyway? It’s hard enough to understand the disease, let alone explain it! […]

Continue reading...

Updates on Treatment

December 18, 2014

0 Comments

“How do you know if you are getting the right drugs at the right doses for treating your myeloma?”

Continue reading...
Scroll Up